TCRT - Alaunos Therapeutics, Inc.
Previous close
1.74
0.040 2.299%
Share volume: 21,765
Last Updated: Mon 13 Jan 2025 10:00:00 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.38%
PREVIOUS CLOSE
CHG
CHG%
$1.70
0.04
0.02%
Summary score
7%
Profitability
0%
Dept financing
23%
Liquidity
48%
Performance
0%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
0%
Return on assets
-29.8%
Return on sales
-174200%
Return on invested capital
0%
Total debt ratio
21.9%
Debt ratio change over timeo
0%
Current Ratio
4.58%
Quick Ratio
0%
Cash Position Ratio
2.69%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
-29.8%
Return on sales
-174200%
Return on invested capital
0%
Total debt ratio
21.9%
Debt ratio change over timeo
0%
Current Ratio
4.58%
Quick Ratio
0%
Cash Position Ratio
2.69%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-27.86%
Return on sales
-174200%
Return on invested capital
0%
Total debt ratio
20.54%
Debt ratio change over time
0%
Current Ratio
4.87%
Quick Ratio
0%
Cash Position Ratio
3.34%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | TCRT | ABBV | AMGN | VRTX |
|---|---|---|---|---|
| Return on equity | 0% | 13.03% | 18.15% | 6.63% |
| Return on assets | -29.8% | 2.28% | 3.22% | 5.84% |
| Return on sales | -174200% | 27.95% | 31.46% | 43.41% |
| Return on invested capital | 0% | 2.07% | 5.53% | 34.89% |
| Profitability | 0% | 45% | 61% | 84% |
| Total debt ratio | 21.9% | 91.02% | 90.77% | 24.67% |
| Debt ratio change over time | 0% | 435.59% | 17.23% | -0.06% |
| Dept financing | 6% | 50% | 26% | 7% |
| Current Ratio | 4.58% | 0.82% | 1.41% | 3.64% |
| Quick Ratio | 0% | 0.71% | 0.99% | 3.42% |
| Cash Position Ratio | 2.69% | 0.31% | 0.49% | 2.77% |
| Liquididy | 46% | 12% | 26% | 73% |
| Short-term ratios | TCRT | ABBV | AMGN | VRTX |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 0% | 5.91% |
| Return on assets | -29.8% | 1.6% | 2.14% | 4.97% |
| Return on sales | -174200% | 24.8% | 18.91% | 42.59% |
| Return on invested capital | 0% | 0% | 0% | 23.7% |
| Profitability | 0% | 23% | 22% | 100% |
| Total debt ratio | 21.9% | 94.49% | 93.35% | 24.56% |
| Debt ratio change over time | 0% | 0% | 0% | -0.62% |
| Dept financing | 31% | 25% | 25% | 6% |
| Current Ratio | 4.58% | 0.82% | 1.41% | 3.64% |
| Quick Ratio | 0% | 0.71% | 0.99% | 3.42% |
| Cash Position Ratio | 2.69% | 0.31% | 0.49% | 2.77% |
| Liquididy | 49% | 12% | 19% | 70% |